G&S Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
G&S Capital's PFE Position: Q3 2024 in Review
G&S Capital sold out of Pfizer (PFE) in Q3 2024, closing a stake of 96,339 shares — an estimated $2.8M sold.
G&S Capital first reported a position in PFE in Q4 2017 and held it in 19 quarters. The position peaked at $2.8M in Q2 2024. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- G&S Capital reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
- G&S Capital sold 96,339 Pfizer shares in Q3 2024, an estimated $2.8M.
- G&S Capital first reported a position in Pfizer in Q4 2017 and held it in 19 quarters.
- G&S Capital's Pfizer position peaked at $2.8M in Q2 2024.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on G&S Capital's 13F filing for Q3 2024, filed 16 Oct 2024.